Suppr超能文献

通过体内抑制肝脂肪酶诱导肾上腺清道夫受体BI并增加高密度脂蛋白胆固醇醚摄取。

Induction of adrenal scavenger receptor BI and increased high density lipoprotein-cholesteryl ether uptake by in vivo inhibition of hepatic lipase.

作者信息

Vieira-van Bruggen D, Kalkman I, van Gent T, van Tol A, Jansen H

机构信息

Department of Biochemistry, Cardiovascular Research Institute Erasmus University Rotterdam (COEUR), 3000 DR Rotterdam, The Netherlands.

出版信息

J Biol Chem. 1998 Nov 27;273(48):32038-41. doi: 10.1074/jbc.273.48.32038.

Abstract

Hepatic lipase (HL) and scavenger receptor type B class I (SR-BI) have both been implicated in high density lipoprotein (HDL)-cholesteryl ester uptake in cholesterol-utilizing tissues. Inactivation of HL by gene-directed targeting in mice results in up-regulation of SR-BI expression in adrenal gland (Wang, N., Weng, W., Breslow, J. L., and Tall, A. R. (1996) J. Biol. Chem. 271, 21001-21004). The net effect on HDL-cholesteryl ester uptake is not known. We determined the impact of acute in vivo inhibition of rat adrenal HL activity by antibodies on SR-BI expression and on human and rat HDL-[3H]cholesteryl ether (CEth) uptake in the adrenal gland. Rat HDL was isolated from rats in which HL activity had been inhibited for 1 h. The rats were studied under basal conditions (not ACTH-treated) and after previous treatment with ACTH for 6 days (ACTH-treated). Intravenous injection of anti-HL resulted in 70% lowering of adrenal HL activity in both conditions which were maintained for at least 8 h. In not ACTH-treated rats, inhibition of adrenal HL increased adrenal SR-BI mRNA (5.2-fold) and mass (1. 6-fold) within 4 h. HL inhibition resulted in 41% and 14% more adrenal accumulation of human HDL-[3H]CEth during 4 and 24 h, respectively. The adrenal uptake of rat HDL-[3H]CEth increased by 68%, 4 h after the antibody injection. ACTH treatment increased total adrenal HL activity from 3.7 +/- 0.5 milliunits to 34.0 +/- 17. 2 milliunits, as well as adrenal SR-BI mRNA from 2.9 +/- 0.7 arbitrary units (A.U.) to 86.8 +/- 41.1 A.U. and SR-BI mass from 7.7 +/- 1.8 A.U. to 63.16 +/- 46.7 A.U. The human HDL-[3H]CEth uptake by adrenals was also significantly increased from 0.58 +/- 0.11% of injected dose to 7.24 +/- 1.58% of injected dose. Inhibition of adrenal HL activity did not result in further induction of SR-BI expression and did not affect human HDL-[3H]CEth uptake. These findings indicate that SR-BI expression may be influenced by changes in HL activity. HL activity is not needed for the SR-BI-mediated HDL-cholesteryl ester uptake by rat adrenal glands.

摘要

肝脂酶(HL)和I类清道夫受体B(SR-BI)均与胆固醇利用组织中高密度脂蛋白(HDL)胆固醇酯的摄取有关。通过基因定向敲除使小鼠体内的HL失活,可导致肾上腺中SR-BI表达上调(Wang, N., Weng, W., Breslow, J. L., and Tall, A. R. (1996) J. Biol. Chem. 271, 21001 - 21004)。但其对HDL胆固醇酯摄取的净效应尚不清楚。我们通过抗体急性体内抑制大鼠肾上腺HL活性,来确定其对SR-BI表达以及人源和大鼠源HDL-[3H]胆固醇醚(CEth)在肾上腺摄取的影响。从HL活性被抑制1小时的大鼠中分离出大鼠HDL。在基础条件下(未用促肾上腺皮质激素处理)以及先前用促肾上腺皮质激素处理6天后(促肾上腺皮质激素处理组)对大鼠进行研究。静脉注射抗HL抗体在两种情况下均使肾上腺HL活性降低70%,且至少维持8小时。在未用促肾上腺皮质激素处理的大鼠中,抑制肾上腺HL后4小时内,肾上腺SR-BI mRNA增加(5.2倍),蛋白量增加(1.6倍)。HL抑制导致人源HDL-[3H]CEth在4小时和24小时的肾上腺蓄积分别增加41%和14%。注射抗体4小时后,大鼠HDL-[3H]CEth的肾上腺摄取增加了68%。促肾上腺皮质激素处理使肾上腺总HL活性从3.7±0.5毫单位增加到34.0±17.2毫单位,肾上腺SR-BI mRNA从2.9±0.7任意单位(A.U.)增加到86.8±41.1 A.U.,SR-BI蛋白量从7.7±1.8 A.U.增加到63.16±46.7 A.U.。肾上腺对人源HDL-[3H]CEth的摄取也显著增加,从注射剂量的0.58±0.11%增加到7.24±1.58%。抑制肾上腺HL活性未导致SR-BI表达进一步诱导,也未影响人源HDL-[3H]CEth摄取。这些发现表明,SR-BI表达可能受HL活性变化的影响。大鼠肾上腺通过SR-BI介导的HDL胆固醇酯摄取不需要HL活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验